Preclinical News and Research

RSS
MaxCyte introduces large scale transfection technology - accelerates cell-based assay development

MaxCyte introduces large scale transfection technology - accelerates cell-based assay development

Raptor Pharmaceuticals initiates phase IIa clinical study for Convivia

Raptor Pharmaceuticals initiates phase IIa clinical study for Convivia

Aida Pharmaceuticals announces development of new anti-cancer drug

Aida Pharmaceuticals announces development of new anti-cancer drug

New drug for melanoma riluzole shows promise

New drug for melanoma riluzole shows promise

Drugs in the pipeline: new therapies that could change treatment strategies

Drugs in the pipeline: new therapies that could change treatment strategies

Restricted calorie diets prevent pancreatic inflammation and cancer

Restricted calorie diets prevent pancreatic inflammation and cancer

Promising Australian cancer drug on show in the U.S.

Promising Australian cancer drug on show in the U.S.

Potential treatment for multiple sclerosis goes to trial

Potential treatment for multiple sclerosis goes to trial

NovoCure presents results from breast cancer pilot study

NovoCure presents results from breast cancer pilot study

Potential new therapy for myeloproliferative disorders

Potential new therapy for myeloproliferative disorders

Skin product decreases malignant melanoma tumor growth according to study

Skin product decreases malignant melanoma tumor growth according to study

NanoViricides begins HIV drug animal trials

NanoViricides begins HIV drug animal trials

Special journal section explores geriatric assessment

Special journal section explores geriatric assessment

FDA approves TREANDA (bendamustine hydrochloride) for chronic lymphocytic leukemia

FDA approves TREANDA (bendamustine hydrochloride) for chronic lymphocytic leukemia

Clinical trial to test a novel HIV/AIDS vaccine

Clinical trial to test a novel HIV/AIDS vaccine

Disappointing resuts for pimecrolimus, investigational anti-restenosis drug

Disappointing resuts for pimecrolimus, investigational anti-restenosis drug

Anticancer siRNA therapy advances, thanks to nanoparticles

Anticancer siRNA therapy advances, thanks to nanoparticles

Experimental drug SGX393 offers new approach to help control drug resistance in leukemia

Experimental drug SGX393 offers new approach to help control drug resistance in leukemia

PharmAthene signs agreement to acquire biodefense vaccines business from Avecia

PharmAthene signs agreement to acquire biodefense vaccines business from Avecia

NanoBio completes interim analysis of phase 2 clinical trial in onychomycosis

NanoBio completes interim analysis of phase 2 clinical trial in onychomycosis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.